Finance

Lists
387690:KOSDAQ
ReMedi Inc
â‚©13,050.00
+17.89%
(+1,980.00) 1D
Aug 18, 11:56:02 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 387690...
Open
â‚©11,300
High
â‚©13,190
Low
â‚©11,180
Mkt. cap
95.32B
Avg. vol.
2.43M
Volume
2.80M
P/E ratio
12.13
52-wk high
â‚©34,650
52-wk low
â‚©6,980
EPS
â‚©1,076
Shares outstanding
7.63M
No. of employees
51
Open
â‚©11,300
High
â‚©13,190
Low
â‚©11,180
Mkt. cap
95.32B
Avg. vol.
2.43M
Volume
2.80M
P/E ratio
12.13
52-wk high
â‚©34,650
52-wk low
â‚©6,980
EPS
â‚©1,076
Shares outstanding
7.63M
No. of employees
51
About ReMedi Inc
CEO-
Employees51
Founded2012
Headquarters-
SectorMedical device
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Mar 2026
Revenue
3.87B
9.38B
Cost of goods sold
2.35B
4.01B
Cost of revenue
2.35B
4.01B
Research and development expenses
655.62M
477.04M
Total research and development expenses
-
-
Selling, general, and admin expenses
1.04B
1.24B
Operating expense
1.75B
2.03B
Total operating expenses
4.10B
6.04B
Operating income
-226.85M
3.34B
Other non operating income
-51.26M
-30.59M
EBT including unusual items
-267.90M
3.52B
EBT excluding unusual items
-267.90M
3.52B
Income tax expense
-
497.71M
Effective tax rate
-
14.15%
Other operating expenses
-
-
Net income
-431.55M
2.81B
Net profit margin
-11.15%
29.93%
Earnings per share
-
-
Interest and investment income
11.44M
5.96M
Interest expense
-
-
Net interest expenses
11.44M
5.96M
Depreciation and amortization charges
39.64M
79.67M
EBITDA
-92.99M
3.53B
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps